mdGroup Germany GmbH – Trademark Portfolio
Entity Type: 16
mdGroup Germany GmbH holds 11 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 11 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 5 Nice Classification classes. Currently, 11 trademarks are registered. Notable registered marks include S, LP360, MDLIDAR, MDMAPPER, and MDTECTOR.
Nerzweg 5
57072 Siegen
Showing of trademarks Trademarks
Trademark Classifications
mdGroup Germany GmbH's trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Insurance; financial affairs; monetary affairs; real estate affairs
Frequently Asked Questions
How many trademarks does mdGroup Germany GmbH have?
mdGroup Germany GmbH has 11 U.S. trademarks filed with the USPTO. Of these, 11 registered.
What trademark classes does mdGroup Germany GmbH file in?
mdGroup Germany GmbH files trademarks across 5 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 9 (Computers & Electronics), Class 39 (Transportation & Storage), Class 12 (Vehicles), Class 36 (Insurance & Financial). Class 42 covers scientific and technological services; industrial analysis and research services.
What are mdGroup Germany GmbH's most well-known trademarks?
mdGroup Germany GmbH's registered trademark portfolio includes well-known marks such as S, LP360, MDLIDAR, MDMAPPER, and MDTECTOR. These are among 11 currently registered trademarks in the portfolio.
What is mdGroup Germany GmbH's trademark registration success rate?
mdGroup Germany GmbH has a 100% trademark registration rate, with 11 out of 11 resolved applications resulting in successful registration. Currently, 0 applications are pending review.